JAM
GILD icon

Jupiter Asset Management’s Gilead Sciences GILD Stock Holding History

Jupiter Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-47,000
Closed -$3.54M – 249
2018
Q1 		$3.54M Hold
47,000
– – 0.11% 185
2017
Q4 		$3.37M Buy
+47,000
New +$3.57M 0.1% 190

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jupiter Asset Management's GILD Position: Q2 2026 in Review

Jupiter Asset Management increased its Gilead Sciences (GILD) stake by 565% in Q2 2026, buying an estimated $152M and bringing the position to 1,357,537 shares worth $172M. The position accounts for 0.85% of the portfolio, ranked #18.

Jupiter Asset Management first reported a position in GILD in Q1 2017 and has held it in 26 quarters since. 2,277 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Jupiter Asset Management held 1,357,537 shares of Gilead Sciences worth $172M as of Q2 2026.
  • Jupiter Asset Management bought 1,153,388 Gilead Sciences shares in Q2 2026, an estimated $152M.
  • Gilead Sciences made up 0.85% of Jupiter Asset Management's portfolio in Q2 2026, its #18 holding.
  • Jupiter Asset Management first reported a position in Gilead Sciences in Q1 2017 and has held it in 26 quarters since.
  • 2,277 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.